Heart pill trial aims to speed recovery after major heart surgery
NCT ID NCT06171802
Summary
This study is testing whether a medication called empagliflozin helps the heart recover better after surgery to replace a narrowed aortic valve. About 205 patients who have this surgery will receive either the real drug or a placebo pill for six months. Researchers will check if the drug reduces heart strain and improves symptoms like shortness of breath compared to the placebo.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AORTIC VALVE STENOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University Hospital of Copenhagen, Rigshospitalet
Copenhagen, 2100, Denmark
Conditions
Explore the condition pages connected to this study.